Patient Care News Personalized Cancer Vaccine Clinical Trial to Expand Following Promising Early Results Nov. 9, 2020 A study investigating a personalized cancer vaccine has reported a 50% response rate for patients with head and neck cancer in its preliminary data. Read more Image Pagination « First First page ‹‹ Previous page 1 2
Personalized Cancer Vaccine Clinical Trial to Expand Following Promising Early Results Nov. 9, 2020 A study investigating a personalized cancer vaccine has reported a 50% response rate for patients with head and neck cancer in its preliminary data. Read more Image